Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer L Hay

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
BMJ Open|July 8, 2026
Development and acceptability of gist-based decision aids for prostate and breast cancer screening: a two-phase qualitative interview study in an online settingSunny Nalavenkata, Oskar Bergengren, Kathleen Lynch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2019
<i>MC1R</i> Variation in a New Mexico PopulationKirsten A M White, Yvonne T Dailey, Dolores D Guest, et al.
Breast Cancer Research and Treatment|February 3, 2017
Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancerJada G Hamilton, Margaux C Genoff, Melissa Salerno, et al.
JAMA Dermatology|May 26, 2018
Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical TrialJennifer L Hay, Kate Zielaskowski, Kirsten Meyer White, et al.
JMIR Research Protocols|April 27, 2017
Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled TrialJennifer L Hay, Marianne Berwick, Kate Zielaskowski, et al.
Journal of Community Genetics|December 8, 2016
Translation and adaptation of skin cancer genomic risk education materials for implementation in primary careVivian M Rodríguez, Erika Robers, Kate Zielaskowski, et al.
Journal of Oncology Practice|January 29, 2019
"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan KetteringJada G Hamilton, Margaux Genoff Garzon, Joy S Westerman, et al.
Journal of Health Psychology|October 9, 2025
Sun protection, sunburn, tanning, and family factors among melanoma survivors and their minor childrenYelena P Wu, Tammy K Stump, Pascal R Deboeck, et al.
Contemporary Clinical Trials|July 1, 2023
The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivorsYelena P Wu, Tammy K Stump, Jennifer L Hay, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
BMJ Open|July 8, 2026
Development and acceptability of gist-based decision aids for prostate and breast cancer screening: a two-phase qualitative interview study in an online settingSunny Nalavenkata, Oskar Bergengren, Kathleen Lynch, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2019
<i>MC1R</i> Variation in a New Mexico PopulationKirsten A M White, Yvonne T Dailey, Dolores D Guest, et al.
Breast Cancer Research and Treatment|February 3, 2017
Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancerJada G Hamilton, Margaux C Genoff, Melissa Salerno, et al.
JAMA Dermatology|May 26, 2018
Interest and Uptake of MC1R Testing for Melanoma Risk in a Diverse Primary Care Population: A Randomized Clinical TrialJennifer L Hay, Kate Zielaskowski, Kirsten Meyer White, et al.
JMIR Research Protocols|April 27, 2017
Implementing an Internet-Delivered Skin Cancer Genetic Testing Intervention to Improve Sun Protection Behavior in a Diverse Population: Protocol for a Randomized Controlled TrialJennifer L Hay, Marianne Berwick, Kate Zielaskowski, et al.
Journal of Community Genetics|December 8, 2016
Translation and adaptation of skin cancer genomic risk education materials for implementation in primary careVivian M Rodríguez, Erika Robers, Kate Zielaskowski, et al.
Journal of Oncology Practice|January 29, 2019
"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan KetteringJada G Hamilton, Margaux Genoff Garzon, Joy S Westerman, et al.
Journal of Health Psychology|October 9, 2025
Sun protection, sunburn, tanning, and family factors among melanoma survivors and their minor childrenYelena P Wu, Tammy K Stump, Pascal R Deboeck, et al.
Contemporary Clinical Trials|July 1, 2023
The Family Lifestyles, Actions and Risk Education (FLARE) study: Protocol for a randomized controlled trial of a sun protection intervention for children of melanoma survivorsYelena P Wu, Tammy K Stump, Jennifer L Hay, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 23, 2013
Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Jennifer L Hay, Thomas M Atkinson, Bryce B Reeve, et al.
Pageof 15